Acrobiosystems for English
icon_bulk_orderAchat groupé/Commande rapide
user
  1. Tableau de bord
  2. Mon profil
  3. Mon adresse
  4. Mes commandes
  5. Adhésion à Acro
Connexion Inscription
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
Il n'y a pas de produit dans le panier !
Mon panier|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > LILRB1

LILRB1

Brief Information

Name:Leukocyte immunoglobulin-like receptor B1
Target Synonym:Leukocyte Immunoglobulin Like Receptor B1,LIR-1,MIR-7,ILT2,LIR1,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1 Soluble Isoform,PIR-B,Leukocyte immunoglobulin-like receptor 1,MIR7,PIRB,CD85j,Immunoglobulin-like transcript 2,Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 1,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1,Monocyte/Macrophage Immunoglobulin-Like Receptor 7,CD85 Antigen-Like Family Member J,Myeloid Inhibitory Receptor 7,
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
CDJ-H82F9 Human Biotinylated Human LILRB1 / CD85j / ILT2 Protein, Fc,Avitag™ (MALS verified)
CDJ-H82F9-structure
CDJ-H82F9-sds
CDJ-H52H6 Human Human LILRB1 / CD85j / ILT2 (23-431) Protein, His Tag (MALS verified)
CDJ-H52H6-structure
CDJ-H52H6-sds
CDJ-H82E8 Human Biotinylated Human LILRB1 / CD85j / ILT2 Protein, His,Avitag™ (MALS verified)
CDJ-H82E8-structure
CDJ-H82E8-sds
CDJ-H52H4 Human Human LILRB1 / CD85j / ILT2 Protein, His Tag (MALS verified)
CDJ-H52H4-structure
CDJ-H52H4-sds
CDJ-C52H3 Cynomolgus Cynomolgus LILRB1 / CD85j / ILT2 Protein, His Tag
CDJ-C52H3-structure
CDJ-C52H3-sds
CDJ-H82F7 Human Biotinylated Human LILRB1 / CD85j / ILT2 Protein, Fc,Avitag™
CDJ-H82F7-structure
CDJ-H82F7-sds
CDJ-H5252 Human Human LILRB1 / CD85j / ILT2 Protein, Fc Tag (MALS verified)
CDJ-H5252-structure
CDJ-H5252-sds
ACRO Quality

Part of Bioactivity data

CDJ-H52H6-SPR
LILRB1 SPR

Biotinylated Human HLA-G&B2M&Peptide (RIIPRHLQL) Complex Protein (Cat. No. HLM-H82E4) captured on Biotin CAP-Series S Sensor Chip can bind Human LILRB1 (23-431) Protein, His Tag (Cat. No. CDJ-H52H6) with an affinity constant of 6.31 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol
CDJ-H52H4-SPR
LILRB1 SPR

Biotinylated Human HLA-G&B2M&Peptide (RIIPRHLQL) Complex Protein (Cat. No. HLM-H82E4) captured on Biotin CAP-Series S Sensor Chip can bind Human LILRB1, His Tag (Cat. No. CDJ-H52H4) with an affinity constant of 10.8 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol

Customer Reviews

Synonym Name

CD85J,LILRB1,CD85,ILT2,LIR1,MIR7

Background

CD85 antigen-like family member J (CD85J) is also known as Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1 or LIR-1), Immunoglobulin-like transcript 2 (ILT-2), Monocyte/macrophage immunoglobulin-like receptor 7 (MIR7), which belongs to leukocyte immunoglobulin-like receptor (LIR) family. CD85J / LILRB1 Contains 4 Ig-like C2-type (immunoglobulin-like) domains. CD85J / LIR-1 is expressed predominantly on B-cells and monocytes.  CD85J is receptor for class I MHC antigens and recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles and is also receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response. CD85J / LILRB1 interaction with HLA-B or HLA-E leads to inhibition of the signal triggered by FCER1A and inhibits serotonin release. CD85J / LILRB1 inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
NGM-707 NGM-707 Phase 2 Clinical Merck & Co, Ngm Biopharmaceuticals Inc Ovarian Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Glioblastoma; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma Details
BND-22 BND-22; SAR-444881 Phase 2 Clinical Biond Biologics Ltd, Sanofi Neoplasms Details
IOS-1002 ios-H2 Phase 1 Clinical ImmunOs Therapeutics AG Solid tumours; Hematologic Neoplasms Details
AGEN-1571 AGEN-1571 Phase 1 Clinical Agenus Inc Solid tumours; Neoplasms Details
NGM-707 NGM-707 Phase 2 Clinical Merck & Co, Ngm Biopharmaceuticals Inc Ovarian Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Glioblastoma; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma Details
BND-22 BND-22; SAR-444881 Phase 2 Clinical Biond Biologics Ltd, Sanofi Neoplasms Details
IOS-1002 ios-H2 Phase 1 Clinical ImmunOs Therapeutics AG Solid tumours; Hematologic Neoplasms Details
AGEN-1571 AGEN-1571 Phase 1 Clinical Agenus Inc Solid tumours; Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Laisser un message

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap